← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2022Last known activity
Sep 15, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (23 distinct, 10 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (12 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Recent trials (12)
- NCT07088757CollaboratorPhase 4Sep 15, 2025
- NCT07078500CollaboratorPhase 2May 5, 2025
- NCT07022223CollaboratorPhase 2Mar 11, 2025
- NCT06520163CollaboratorPhase 3Aug 31, 2024
- NCT06520176CollaboratorPhase 3Aug 31, 2024
- NCT06452147CollaboratorN/AJun 19, 2024
- NCT06925334CollaboratorPhase 4May 20, 2024
- NCT05921695CollaboratorN/AMay 28, 2023
- NCT06234514Lead sponsorPhase 4Jan 1, 2023
- NCT06234514OfficialPhase 4Jan 1, 2023
- NCT06234514Sponsor investigatorPhase 4Jan 1, 2023
- NCT05722405CollaboratorPhase 4Jul 1, 2022
Details
- Last known activity
- Sep 15, 2025